Keywords: merck, kgaa, revenues, core, eps, rocket, 4th-qtr

Merck KGaA revenues, core EPS rocket but 4th-qtr operating results slump 21%

Article | 25 February 2008

Print This

German pharmaceutical and chemicals group Merck KGaA saw significant impact from the acquisition of Swiss biotechnology firm Serono and the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in